PFE icon

Pfizer
PFE

Overview Fund Activity

1,963 hedge funds and large institutions have $134B invested in Pfizer in 2016 Q1 according to their latest regulatory filings, with 113 funds opening new positions, 920 increasing their positions, 728 reducing their positions, and 92 closing their positions.

Holders
1,963
Holders Change
-3
Holders Change %
-0.15%
% of All Funds
52.39%
Holding in Top 10
201
Holding in Top 10 Change
-52
Holding in Top 10 Change %
-20.55%
% of All Funds
5.36%
New
113
Increased
920
Reduced
728
Closed
92
Calls
$3.49B
Puts
$3.78B
Net Calls
-$287M
Net Calls Change
+$873M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$3.14B
2
Bank of America
2
Bank of America
North Carolina
$3.07B
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$4.04B
4
BA
4
BlackRock Advisors
Delaware
$1.54B
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.2B

Top Sellers

1
Boston Partners
1
Boston Partners
Massachusetts
$170M
2
DCM
2
Discovery Capital Management
Connecticut
$0
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$240M
4
State Street
4
State Street
Massachusetts
$9.01B
5
IG
5
ING Group
Netherlands
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JGC
2076
J. Goldman & Co
New York
– – – –
ACM
2077
Anandar Capital Management
New York
– – – –
BO
2078
Bach Option
Hong Kong
– – – –
MCM
2079
Moore Capital Management
New York
– – – –
EAM
2080
EverPoint Asset Management
Connecticut
– – – –
KM
2081
Kalos Management
Georgia
– – – –
APCM
2082
Arbiter Partners Capital Management
New York
– – – –
RFA
2083
Reilly Financial Advisors
California
– – – –
KPF
2084
K2 Principal Fund
Ontario, Canada
– – – –
CPM
2085
Chesapeake Partners Management
Maryland
– – – –
SFM
2086
Soros Fund Management
New York
– – – –
80 81 82 83
84